The hybridomas generated from the fusion of CD40L-stimulated cells with plasmacytomas were cultured and their supernatants screened for IgG secretion and vaccine peptide binding by ELISA (Fig. 3). The gene discussed is CD40LG; the disease is plasmacytoma.